QOL-20. Low-dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study.

Conference Paper

QOL-20

Full Text

Duke Authors

Cited Authors

  • Peters, K; Affronti, ML; Woodring, S; Lipp, E; Healy, P; McShwrry, F; Herndon, J; Flahiff, C; Miller, E; Freeman, M; Minchew, J; Zalutsky, B; Taylor, B; Boulton, S; Randazzo, D; Desjardins, A; Vlahovic, G; Bigner, D; Friedman, H

Duke Editors

Duke Contributors

Published In

Volume / Issue

  • 17 / Suppl 5

Start / End Page

  • v192 - v192

Published By

International Standard Serial Number (ISSN)

  • 1522-8517

Digital Object Identifier (DOI)

  • 10.1093/neuonc/nov230.20

Conference Name

  • 20th Annual Scientific Meeting and Educations Day of the Society for Neuro-Oncology

Conference Location

  • San Antoni, TX

Conference Start Date

  • November 19, 2015

Conference End Date

  • November 22, 2015